AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03754582 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Perampanel
Description: Intravenous infusion.
Study NCT02240823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: adipose derived stem cells
Study NCT02116647 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoanalytic therapy
Study NCT01758224 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Magnetic Stimulation
Description: The magnetic stimulation protocol (plan of study) consists of a daily expiratory (breathing out) muscle conditioning program (20 minutes). A magnetic coil will be placed on participant's back to stimulate the nerves related to the breathing function. Each stimulation will last two seconds and the time between each stimulation is about half a minute. The training session will begin with low intensity FMS for 20 minutes daily. The FMS stimulation intensity will gradually increase during the 6-week training period.
Study NCT01758224 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resistive Expiratory Muscle Training
Description: The REMT training will take place in the FMS lab using a standard resistive breathing device. After training, participants will perform the exercise for 20 minutes daily (5days each week for 6 weeks) in their home. Participants will wear a nose clip when performing the breathing exercise. The exercise protocol will begin with a low resistance level for 20 minutes a day. The resistance level will gradually increase during the 6-week training period.
Study NCT04123912 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kinesio Taping - Functional Movement Power Training
Description: Subjects assigned to the Kinesio Taping - Functional Movement Power Training (KT-FMPT) group will receive FMPT concurrent with KT. The FMPT protocol was developed by the research team with reference to common physiotherapeutic exercises for children with motor disabilities.9 It comprises 5 functional movement exercises and 6 lower-limb power/resistance training exercises using weights or resistance bands.
Study NCT04123912 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Jogging with placebo taping
Description: Subjects assigned to the control group will receive no FMPT or KT, but participate in a jogging intervention with placebo tape applied on their calf muscles and removed after the intervention.
Study NCT02386891 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thermal Environment
Study NCT02763254 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: baltaleucel-T
Description: Autologous EBV-specific T cells
Study NCT06350942 — intervention group
Intervention type: PROCEDURE
Intervention: one trocar-assisted retroperitoneoscopic ureteroureterostomy (OTAU)
Description: A 12 mm transverse incision was made just above the iliac crest, followed by careful dissection of the fascia and muscle layer to expose the Gerota's fascia. Entry into the retroperitoneal space was achieved with a 10-mm balloon trocar, allowing for pneumoretroperitoneum establishment. Using a 10-mm laparoscope equipped with a Maryland dissector, the ureters were dissected and isolated, followed by careful exteriorization of both upper and lower pole moiety ureters with a Babcock grasper. The pathological upper pole moiety ureter was transected, preserving the normal lower pole moiety ureter and shared blood supply, and closed with a Vicryl 4/0 suture. Subsequently, an end-to-side ureteroureterostomy was performed with a 6/0 Polydioxanone running suture, with antegrade insertion of a double J stent if not previously conducted. A final retroperitoneoscopic evaluation ensured proper anastomosis alignment, and the incision was closed without drainage.
Study NCT04018976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AVACEN 100
Description: The AVACEN 100 pulls a -30mmHg vacuum around the hand from the wrist down and applies heat (108 Fahrenheit) to the palm
Study NCT04018976 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AVACEN 100 heat only
Description: The AVACEN 100 applies heat (108 Fahrenheit) to the palm
Study NCT04018976 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: AVACEN 100 sham
Description: The AVACEN 100 does not provide heat or vacuum
Study NCT01819129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Faster-acting insulin aspart
Description: Mealtime FIAsp administered subcutaneously (s.c., under the skin). Dose individually adjusted.
Study NCT01819129 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin aspart
Description: Mealtime insulin aspart administered subcutaneously (s.c., under the skin). Dose individually adjusted.
Study NCT01819129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Description: Administered s.c. once daily at subjects' pre-trial dose. Subjects will continue their metformin treatment without changing the frequency or dose throughout the trial.
Study NCT01819129 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin glargine
Description: Administered s.c. once daily at subjects' pre-trial dose. Subjects will continue their metformin treatment without changing the frequency or dose throughout the trial.
Study NCT01084980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: tacrolimus 0.05mg/kg bid for 12 weeks corticosteroid 0.3 - 0.5mg/kg qd
Study NCT02779907 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: No interventions planned for this observational study
Study NCT03511508 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ChroPreg + standard care
Description: * Ongoing update of individual maternity care plan.~* Extra consultation with the specialized midwife at 20-24 weeks of pregnancy about psychological well-being during pregnancy.~* Extra consultation with the specialized midwife at 30-33 weeks of pregnancy about individual birth preparation, breastfeeding and post-partum care.~* Possibility for psychologist consultation.~* Post-partum: Telephone follow-up by the specialized midwife 1 and 2 weeks after discharge.~* Postnatal follow-up: 4-6 weeks after delivery: conversation with specialized midwife about the pregnancy and birth.
Study NCT01790282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: estradiol plus progesterone 100 mg IM injection
Description: estradile valaerate 2mg plus progesterone 100 mg/day support arm :E2 valerate 2mg three times /day are given to the arm cases plus P4 100 IM/day for 14 days starting on day of ovum pickup and single IM injection of 0.1 mg decapeptyl on day of ET
Study NCT01790282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Progesterone IM of 100 mg
Description: Starting on day of ovum pickup ICSI cases are given prontogest 100 mg IM /day plus single dose dose of treptorline 0.1mg is given sc on day of embryo transfer
Study NCT01790282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Progesterone IM of 100 mg
Description: Starting on day of ovum pickup ICSI cases are given prontogest 100 mg IM /day plus single dose dose of treptorline 0.1mg is given sc on day of embryo transfer
Study NCT01545882 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Degarelix
Description: Treatment will consist of a starting dose of 240mg injected subcutaneously (s.c) and monthly s.c. maintenance doses of 80mg for a total duration of 6 months.
Study NCT02540330 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant
Study NCT02540330 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fulvestrant
Study NCT04127357 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: 1450 ppm fluoride toothpaste brushing x Resin sealing (FluroShield, Dentsply, Brazil).
Description: After randomization of the children, the selected molars were allocated through a randomized sequence list in 2 groups: A. Brushing with 1450 ppm fluoride toothpaste, donated by the researcher; B. Resin Sealing (FluroShield, Dentsply, Brazil).~The teeth included in the second group (group B) underwent a second randomization: B1. With absolute isolation; B2. With relative isolation. For the group with absolute isolation, topical anesthesia and local papillary infiltration were performed for subsequent staple placement. Relative isolation was performed with cotton rollers and moisture control suction. The sealant selected was the opaque fluroshield to facilitate visualization upon visual examination during reevaluations and was applied following the manufacturer's standards. The teeth were clinically and radiographically followed at 6 and 12 months and two sessions of motivation reinforcement were performed through video and brush change at 3 and 9 months.
Study NCT04127357 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 1450 ppm fluoride toothpaste brushing x Resin sealing (FluroShield, Dentsply, Brazil).
Description: After randomization of the children, the selected molars were allocated through a randomized sequence list in 2 groups: A. Brushing with 1450 ppm fluoride toothpaste, donated by the researcher; B. Resin Sealing (FluroShield, Dentsply, Brazil).~The teeth included in the second group (group B) underwent a second randomization: B1. With absolute isolation; B2. With relative isolation. For the group with absolute isolation, topical anesthesia and local papillary infiltration were performed for subsequent staple placement. Relative isolation was performed with cotton rollers and moisture control suction. The sealant selected was the opaque fluroshield to facilitate visualization upon visual examination during reevaluations and was applied following the manufacturer's standards. The teeth were clinically and radiographically followed at 6 and 12 months and two sessions of motivation reinforcement were performed through video and brush change at 3 and 9 months.
Study NCT01900106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: abacavir/lamivudine + raltegravir
Description: abacavir/lamivudine + raltegravir
Study NCT01900106 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: abacavir/lamivudine + darunavir/ritonavir
Description: abacavir/lamivudine + darunavir/ritonavir
Study NCT04083261 — intervention group
Intervention type: OTHER
Intervention: DNA Genotek Oragene 600
Description: Saliva-based DNA sample collection kit
Study NCT04084548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine and ketamine
Description: Perioperative lidocaine and ketamine infusion (see below for dosages and timings)
Study NCT04084548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: Perioperative lidocaine infusion (1.5 mg/kg bolus followed by an infusion of 2 mg/kg/hour based on actual body weight; the bolus and infusion will be started after anesthesia induction and before surgical incision, and continued until 1 hour after transfer from the operating room to the PACU)
Study NCT04084548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Perioperative ketamine infusion (0.5 mg/kg bolus followed by an infusion of 0.3 mg/kg/hour based on actual body weight; the bolus and infusion will be started after anesthesia induction and before surgical incision, and continued until 1 hour after transfer from the operating room to the PACU)
Study NCT04084548 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Perioperative placebo infusion (normal saline)
Study NCT03625830 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting PTCA-Balloon Catheter(SeQuent® Please)
Description: SeQuent® Please in length of 10 mm, 15 mm, 17 mm, 20 mm, 26 mm, 30 mm and in diameter of 2.0 mm, 2.5mm, 2.75mm will be used in the trial.
Study NCT03625830 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: rapid exchange PTCA -Balloon Catheter (SeQuent® Neo)
Description: SeQuent® Please in length of 10 mm, 15 mm, 17 mm, 20 mm, 26 mm, 30 mm and in diameter of 2.0 mm, 2.5mm, 2.75mm will be used in the trial.
Study NCT01663701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simplified severe sepsis protocol
Description: This protocol consists of an early aggressive fluid strategy, and, when appropriate, blood transfusion and titratable dopamine. Monitoring is based on physical exam findings.
Study NCT01663701 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Patients are managed according to admitting doctors' orders
Study NCT02881112 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Provant Therapy System
Description: Treatment with the Provant Therapy System
Study NCT04088084 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: palmitoylethanolamide (PEA) 600 mg
Description: PEA 600 mg was added to topical therapy
Study NCT02545114 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tolvaptan
Description: Use of Tolvaptan to treat SIADH-induced hyponatremia in selected patients with acute neurological injuries.
Study NCT02649374 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary, Exercise and lifestyle modifications
Description: Women without GDM will receive advise on diet, exercise and lifestyle modifications similar to what is advised to women with GDM
Study NCT00278369 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aldesleukin
Description: The IL-2 is given as a 15-minute infusion through an intravenous catheter (I.V.), a small plastic tube that is put into your vein for the time you are receiving the study treatment. IL-2 is given through the I.V. once every 8 hours for 5 days (days 1-5). A second 5 day cycle of IL-2 will begin on the 15th day (days 15-19). This is one complete cycle (days 1-19) of IL-2 treatment
Study NCT00278369 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: denileukin diftitox
Description: Denileukin diftitox will be administered once daily as a 15 to 60 minute infusion for 3 consecutive days.
Study NCT04218838 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CornerLoc SI Joint Stabilization Procedure
Description: CornerLoc minimally invasive SI Joint Stabilization System
Study NCT04218838 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular Sacroiliac Joint Steroid Injection
Description: Standard of Care - Steroid injection into the sacroiliac joint
Study NCT02085096 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy
Description: Problem-solving therapy programs have been shown to be effective among parents of children diagnosed with cancer. Efforts have been made to apply this same strategy to spouses/significant others of men diagnosed with prostate cancer. The purpose of this study is to test the efficacy of problem-solving therapy on the spouses of prostate cancer patients.
Study NCT02085096 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Problem-Solving Therapy
Description: Problem-solving therapy programs have been shown to be effective among parents of children diagnosed with cancer. Efforts have been made to apply this same strategy to spouses/significant others of men diagnosed with prostate cancer. The purpose of this study is to test the efficacy of problem-solving therapy on the spouses of prostate cancer patients.
Study NCT01824329 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prostate capsule sparing cystectomy
Description: Removes the adenoma and prostatic urethra along with the urinary bladder, but leaves in situ the prostatic capsule and subsequently the surrounding neurovascular bundle.
Study NCT01824329 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nerve sparing cystectomy
Description: Attempts to spare the cavernosal nerves that travel immediately adjacent to the lateral prostate and are routinely divided during a standard RCP.
Study NCT03657563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positive psychological intervention
Description: Participants in the intervention group are required to record three good things every night before sleeping for five days a week using WeChat. Such things could be ordinary, minor or important.~WeChat is a common communication tool used in China, just like Facebook, basic messages could be sent individually and posting pictures or texts is also available.
Study NCT01824901 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD4547
Description: Given PO
Study NCT00607412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated psychotherapy for PTSD and substance use
Description: integrated, present focused psychotherapy for PTSD and substance use disorders tailored to women who have experienced intimate partner violence
Study NCT00607412 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 12-step based supportive therapy
Description: supportive psychotherapy based on 12-step model
Study NCT00844051 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: School-based influenza vaccination program
Description: School-based influenza vaccination program
Study NCT01365234 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pacing Lead
Description: Implant and follow up of Model 20066 lead
Study NCT03468816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sensor activation (on DryMax Extra Soft)
Description: Study profile of sensor activation
Study NCT05966428 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Exercises
Description: This conventional exercises included stretching and strengthening, balance-coordination, mobility and range of motion exercises.~The control group received conventional therapy 3 days a week for 8 weeks. Each therapy session a day lasted 45 minutes in control group.
Study NCT05966428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Exercises
Description: This conventional exercises included stretching and strengthening, balance-coordination, mobility and range of motion exercises.~The control group received conventional therapy 3 days a week for 8 weeks. Each therapy session a day lasted 45 minutes in control group.
Study NCT05966428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensory Integration Therapy
Description: The Sensory Integration Therapy was applied to the intervention group in addition to the conventional exercise program. Sensory Integration Therapy included tactile, proprioceptive, and vestibular activities. The tactile sensory activities consisted of materials such as stepping stones, tactile box, brushing, fabric walking path. The vestibular sensory activities consisted of materials such as hammock swings, trampolines, rope nets, rock walls, river stones. Proprioceptive sensory activities consisted of materials such as weight bearing activities, heavy lifting, deep pressure, big ball activities, tug of war and ball pits.~The intervention group underwent each session 45 minute conventional therapy and 15 minutes SIT. The therapy program continued 3 days a week for 8 weeks in intervention group.
Study NCT01297361 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood Sample
Description: Blood sampling for diagnosis of vitamins deficiencies
Study NCT03511625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acthar Injectable Product
Description: Acthar is a non-specific melanocortin receptor agonist
Study NCT03511625 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Depo medrol
Description: Depo medrol is an anti-inflammatory glucocorticoid
Study NCT03049267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apremilast
Description: Fifteen patients will be supplied of apremilast for daily oral use; 16 weeks.
Study NCT03049267 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Five patients will be supplied with placebo tablets with identical labeling as apremilast for daily use; 16 weeks.
Study NCT00701142 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Haemocomplettan® P
Description: Single intravenous infusion
Study NCT00701142 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline solution
Description: Single intravenous infusion
Study NCT04610489 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Quidel Sofia SARS Antigen FIA
Description: Obtained via bilateral mid-turbinate swab.
Study NCT01174004 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pimavanserin tartrate
Description: pimavanserin tartrate, 40 mg, tablet, once daily by mouth for 6 weeks
Study NCT01174004 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo, tablet, once daily by mouth for 6 weeks
Study NCT02520050 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional MNT
Description: Will follow the nutritional recommendations set by the American Diabetes Association in 2013.
Study NCT01360372 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylnaltrexone
Description: Methylnaltrexone 8 mg IV for subjects 38 to 62 kg body weight, Methylnaltrexone12 mg IV for subjects 62.1 to 114 kg body weight
Study NCT01360372 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline injection
Description: Saline 0.4 to 0.8 ml injection
Study NCT02520050 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured MNT
Description: Will follow a meal plan developed at Joslin plus use of use of diabetes-specific nutritional formula.
Study NCT02520050 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured MNT plus Weekly Support
Description: Will follow a meal plan developed at Joslin plus use of use of diabetes-specific nutritional formula; in addition to receiving weekly coaching from a registered dietitian
Study NCT02050074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colesevelam
Study NCT02050074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Study NCT02050074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo